What is the pathophysiology of hyperosmolar hyperglycemic state (HHS) in older adults with type 2 diabetes, particularly when precipitated by infection, cardiovascular disease, or diuretic use?

Pathophysiology of Hyperosmolar Hyperglycemic State (HHS)

HHS results from relative insulin deficiency that is sufficient to prevent ketosis but inadequate to prevent severe hyperglycemia, combined with elevated counterregulatory hormones and progressive osmotic diuresis leading to profound dehydration and hyperosmolarity. 1

Core Metabolic Derangements

The fundamental pathophysiology involves a reduction in net effective insulin action coupled with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, and growth hormone) 1. This hormonal imbalance triggers:

Glucose Metabolism Disruption

• Increased hepatic and renal glucose production with impaired peripheral glucose utilization in muscle and adipose tissue
• Results in severe hyperglycemia (typically >600 mg/dL) and increased extracellular osmolality 1

Key Distinction from DKA

HHS involves plasma insulin concentrations that are inadequate for glucose utilization but adequate (based on residual C-peptide) to prevent lipolysis and ketogenesis 1. This explains the absence of significant ketoacidosis despite profound hyperglycemia, though the evidence for this mechanism remains weak 1.

Osmotic Consequences

• Glycosuria triggers osmotic diuresis with massive losses of water, sodium, potassium, and other electrolytes 1
• Progressive dehydration leads to hypovolemia, decreased glomerular filtration rate, and prerenal azotemia 2
• This creates a vicious cycle: reduced renal clearance worsens hyperglycemia, which intensifies osmotic diuresis

Age-Specific Pathophysiologic Factors

Older adults are particularly vulnerable to HHS due to multiple physiologic changes 2:

Aging-Related Metabolic Changes

• Reduced glucose-induced insulin release from pancreatic beta cells
• Increased insulin resistance in peripheral tissues, especially muscle and adipose tissue 2
• Abdominal obesity with elevated free fatty acids and inflammatory markers (TNF-α, IL-6) that worsen insulin resistance 2

Renal and Thirst Mechanisms

• Elevated renal threshold for glucose fails to correct hyperglycemia through osmotic diuresis 3
• Reduced glomerular filtration rate limits glucose excretion 3
• Impaired thirst mechanisms prevent adequate fluid intake despite severe dehydration 2, 3

Precipitating Factors and Their Mechanisms

Infection (Most Common)

Infection is the leading precipitant, triggering release of proinflammatory cytokines that interfere with carbohydrate metabolism 2, 1. This includes:

• Pneumonia and respiratory infections
• Genitourinary infections
• Any systemic infection

Cardiovascular Disease

Acute cardiovascular events (myocardial infarction, stroke, heart failure) elevate counterregulatory hormones and may limit fluid intake 1, 4

Medication-Induced

Diuretics, β-blockers, and glucocorticoids adversely affect carbohydrate metabolism 2:

• Thiazides impair insulin secretion and increase insulin resistance
• Corticosteroids increase hepatic glucose production
• Sympathomimetic agents (dobutamine, terbutaline) elevate counterregulatory hormones 1

Detrimental Effects of Severe Hyperglycemia

Immune Dysfunction

Hyperglycemia impairs leukocyte function including 2:

• Decreased phagocytosis
• Impaired bacterial killing
• Reduced chemotaxis
• This leads to increased hospital infections and poor wound healing

Inflammatory Cascade

• Activation of nuclear factor κB (NF-κB) and production of proinflammatory cytokines 2
• Oxidative stress causing increased vascular permeability and mitochondrial dysfunction 2

Vascular Dysfunction

Endothelial impairment through suppressed nitric oxide formation and impaired flow-mediated dilation 2

Clinical Evolution

HHS typically evolves over several days to weeks (unlike DKA which develops within 24 hours) 1. This prolonged evolution allows:

• Progressive dehydration (often 8-10 liters total body water deficit)
• Extreme hyperosmolarity (>320 mOsm/kg)
• Frequent altered mental status or coma (more common than in DKA) 1

Critical Pitfalls

Elderly patients often lack classic symptoms (polyuria, polydipsia) due to elevated renal threshold and impaired thirst 2. They may present only with:

• Weight loss and fatigue (attributed to "old age")
• Confusion or altered mental status
• Failure to thrive 2

Hypothermia, if present, is a poor prognostic sign despite infection being a common precipitant 1. Patients can be normothermic or hypothermic due to peripheral vasodilation.

Mortality remains high at 15% (compared to 5% for DKA), worsened by extremes of age, coma, and hypotension 1. Recent data shows mortality varies significantly by region, ranging from 4.8% in North America to 40% in Africa 5.